Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Sarcoma

703 product results for "Sarcoma"

Options+
Options
Confirm
  • Product types
    0 selected
    Assay Kit (419)
    Research Biosimilar (59)
    Research Biosimiliar (2)
    Antibodies (154)
    Proteins (60)
  • Expression system
    0 selected
    E. coli (37)
    Mammalian Cells (81)
  • Target
    0 selected
    Dilpacimab (1)
    Natalizumab (2)
    Otilimab (1)
    gB/Envelope glycoprotein B (1)
    Tarextumab (1)
    Zagotenemab (1)
    Imlifidase (5)
    VEGF (1)
    E8L (5)
    Figitumumab (1)
    Palivizumab (3)
    ENPP7 (1)
    Losatuxizumab (1)
    sCD14 (1)
    Spike glycoprotein E1 (2)
    Simlukafusp Alfa (1)
    PROK1/EG-VEGF (2)
    Enfortumab (1)
    Spike glycoprotein (10)
    Ibalizumab (1)
    CD340/ERBB2 (1)
    Tocilizumab (3)
    Tibulizumab (1)
    Tosatoxumab (1)
    Mazdutide (2)
    RBD (Beta) (1)
    Rituximab (1)
    Cergutuzumab (1)
    Glembatumumab (1)
    Indatuximab (1)
    Alacizumab (1)
    Protein A (1)
    VEGFA & CD279/PD-1 (1)
    Tremelimumab (1)
    LAMTOR4 (1)
    SLITRK6 (6)
    Andecaliximab (1)
    Vofatamab (1)
    Ivuxolimab (1)
    WRAP53 (1)
    TP53TG5 (1)
    PD1 / VEGF-A (2)
    RB1CC1 (1)
    Labetuzumab (1)
    Balstilimab (1)
    Navicixizumab (1)
    Faricimab (1)
    gE/Envelope glycoprotein E (1)
    Frovocimab (1)
    Vascular permeability factor (1)
    A35R (5)
    Canakinumab (1)
    Ustekinumab (3)
    Ganitumab (1)
    Suptavumab (1)
    Necitumumab (1)
    F/Fusion glycoprotein F0 (5)
    Zenocutuzumab (1)
    dsRNA (1)
    Epcoritamab (1)
    Spike Protein (Trimer) (2)
    Tregalizumab (1)
    IL1RL1/ST2 (1)
    DEPTOR (1)
    Vunakizumab (1)
    Adalimumab (3)
    RBD (Gamma) (1)
    p-TP53 (1)
    Ramucirumab (1)
    Human β Amyloid (1-42) (1)
    Zalifrelimab (1)
    Bimagrumab (1)
    RRM2B (1)
    Pogalizumab (1)
    Icrucumab (1)
    Itolizumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    Crizanlizumab (1)
    Iscalimab (1)
    EML4-ALK (1)
    Belantamab (1)
    C3 & C4B & VEGFA (1)
    RBD (E484K) (1)
    Cetrelimab (1)
    Atezolizumab (3)
    Nesvacumab (1)
    Sotrovimab (1)
    KITLG/SCF (1)
    Milatuzumab (1)
    gD/Envelope glycoprotein D (1)
    Urelumab (1)
    Befovacimab (1)
    CD140a/PDGFRA (21)
    Lodelcizumab (1)
    RB1 (2)
    VEGF-A (1)
    A29L (6)
    Gevokizumab (1)
    B6R/SL-159 (1)
    Teprotumumab (1)
    Afasevikumab (1)
    Panitumumab (3)
    Guselkumab (3)
    ATP7B (1)
    Glofitamab (1)
    Ianalumab (1)
    Benufutamab (1)
    NP/Nucleocapsid (5)
    Zanolimumab (1)
    dsDNA (1)
    Lacnotuzumab (1)
    Retatrutide (1)
    Obiltoxaximab (1)
    LAMTOR3 (2)
    MDM4 (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    Ascrinvacumab (1)
    Human β Amyloid (1-40) (1)
    PD-L1 & VEGF (1)
    PDL1 & VEGF (1)
    Farletuzumab (1)
    Oxelumab (1)
    Tavolimab (1)
    Inclacumab (1)
    TP53BP1 (2)
    Teclistamab (1)
    SS18 (1)
    Certolizumab (2)
    RBD (Kappa) (1)
    Cabiralizumab (1)
    Nivolumab (3)
    Avelumab (3)
    Vanucizumab (1)
    Casirivimab (1)
    gC/Envelope glycoprotein C (1)
    Utomilumab (1)
    Concizumab (1)
    IL6 (1)
    SARS-CoV-2 Neutralization Antibody (3)
    ACVR1/ALK-2 (6)
    Bimekizumab (1)
    Suvizumab (1)
    Serclutamab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    ACVR1C (1)
    Clazakizumab (1)
    TPP15 (1)
    Amatuximab (1)
    Ibritumomab (1)
    ERAP1 (1)
    Glycoprotein (5)
    Tiragolumab (2)
    β-D-Glucan (1)
    ACVRL1/ALK-1 & VEGFA (1)
    TAU pT181 (1)
    Edrecolomab (1)
    Daratumumab (3)
    FGF2/bFGF & VEGFA (1)
    Mirvetuximab (1)
    ACVR1B (1)
    Lirilumab (1)
    Ieramilimab (1)
    Cusatuzumab (1)
    cAMP (1)
    PD-L1 / VEGF-A (1)
    VEGFB (7)
    Varlilumab (1)
    LAMTOR5/HBXIP (2)
    CD140b/PDGFRB (17)
    Gremubamab (1)
    RBD (Delta Plus) (1)
    Emactuzumab (1)
    Pembrolizumab (3)
    Durvalumab (3)
    Imdevimab (1)
    Disitamab (1)
    gC/UL44 (1)
    Marstacimab (1)
    Tezepelumab (1)
    Etanercept (3)
    Basiliximab (1)
    RBD (Omicron/BA.5) (3)
    Apamistamab (1)
    Ixekizumab (1)
    Olokizumab (1)
    TPP17 (1)
    Anetumab (1)
    Mosunetuzumab (1)
    PDGFC (5)
    Blosozumab (1)
    CDK4 (2)
    CXCL17/DMC/VCC1 (1)
    Conatumumab (1)
    Romiplostim (2)
    Eldelumab (1)
    M/Matrix protein (2)
    Sacituzumab (1)
    CD292/BMPR1A (7)
    VEGFA & ANG-2 (3)
    Tisotumab (1)
    Oleclumab (1)
    Cinpanemab (1)
    TAU pT217 (1)
    VEGFC (2)
    VEGFA & ANGPT2/ANG-2 (1)
    TRIAP1 (1)
    Bevacizumab (3)
    Glycoprotein G (2)
    Vorsetuzumab (1)
    Olaratumab (1)
    Enoblituzumab (1)
    Siltuximab (3)
    Vascular endothelial growth factor A (1)
    M1R (5)
    TP53 (1)
    Golimumab (3)
    Semaglutide (2)
    EWSR1 (2)
    Spike glycoprotein (RBD) (1)
    Sintilimab (1)
    TP53/p53 (16)
    Pacmilimab (1)
    Lupartumab (1)
    Pertuzumab (3)
    gD/US6 (1)
    Magrolimab (1)
    ACVRL1/ALK-1 (18)
    Camidanlumab (1)
    NP/Nucleoprotein (3)
    Remtolumab (1)
    Foravirumab (1)
    Tesidolumab (1)
    Elotuzumab (1)
    Sarilumab (2)
    Sirukumab (1)
    TPP47 (1)
    Ocaratuzumab (1)
    Romosozumab (1)
    Drozitumab (1)
    Eculizumab (3)
    Tirzepatide (2)
    Tovetumab (1)
    Talacotuzumab (1)
    CD274/PD-L1 & VEGFA (1)
    Rolinsatamab (1)
    Ifabotuzumab (1)
    vegfab (2)
    Brolucizumab (1)
    VEGF-C/VEGF-D (1)
    Codrituzumab (1)
    Mavezelimab (1)
    Lenzilumab (1)
    GP/Envelope glycoprotein (4)
    CD246/ALK (9)
    Pasotuxizumab (1)
    Semorinemab (1)
    Mirzotamab (1)
    VPF (1)
    Evolocumab (1)
    Cixutumumab (1)
    Tislelizumab (1)
    Denosumab (3)
    Trastuzumab (2)
    US8/gE (1)
    EZH2 (3)
    Obinutuzumab (2)
    Elezanumab (1)
    RBD (6)
    p53 (R175H mutation) pHLA Complex (1)
    Daclizumab (1)
    RBD (Omicron/JN.1) (1)
    MDM2 (4)
    Emibetuzumab (1)
    Secukinumab (2)
    Rafivirumab (1)
    RBD (WT) (1)
    Ziltivekimab (1)
    G/Major surface glycoprotein G (1)
    SS18L1 (1)
    Ontamalimab (1)
    CD20/MS4A1 (3)
    Lexatumumab (1)
    Aflibercept (1)
    Vibecotamab (1)
    Imalumab (1)
    Zampilimab (1)
    CD79B (2)
    ATRX/RAD54L (3)
    MTOR (4)
    Ranibizumab (3)
    DLL4 & VEGFA (3)
    Exenatide acetate (2)
    TIGAR (1)
    Favezelimab (1)
    Meplazumab (1)
    cGMP (1)
    Tigatuzumab (1)
    Namilumab (1)
    gG/US4 (2)
    Rosopatamab (2)
    Tilavonemab (1)
    CD117/KIT (24)
    Omburtamab (1)
    VEGFA (41)
    H3L (3)
    Infliximab (2)
    Alirocumab (1)
    Dalotuzumab (1)
    EPO/Erythropoietin (1)
    Toripalimab (1)
    Nirsevimab (1)
    Depatuxizumab (1)
    Cetuximab (3)
    RICTOR (1)
    Zanidatamab (1)
    Spike glycoprotein E2 (2)
    Sibrotuzumab (1)
    Afutuzumab (1)
    RBD (Delta) (3)
    RBD (Omicron/KP.2) (1)
    SLITRK5 (1)
    Tanezumab (1)
    RBD (Alpha) (1)
    Omalizumab (2)
    N/Nucleoprotein (1)
    Carlumab (1)
    Mirikizumab (2)
    BSA (1)
    RPTOR (1)
    Ipilimumab (2)
    VEGF/ANG-2 (1)
    TGFBR1 (1)
    Anifrolumab (1)
    Letolizumab (1)
    Varisacumab (1)
    Dupilumab (3)
    Astegolimab (1)
  • Species
    0 selected
    Homo sapiens (Human) (9)
    Canis lupus familiaris (1)
    Human (88)
    Canis lupus familiaris (Dog) (6)
    Mouse (10)
    Rat (1)
    Mus musculus (Mouse) (1)
    Zebrafish (1)
    Felis catus (Cat) (4)
  • Applications
    0 selected
    ELISA (657)
    RIA (1)
    SPR (2)
    IHC (56)
    SDS-PAGE (60)
    Research in vivo (4)
    WB (124)
    Immunogen (60)
    FACS (6)
    Bioactivity testing in progress (38)
    Bioactivity: FACS (55)
    FuncS (1)
    Functional assay (6)
    Neutralization (1)
    Functional assay (61)
    IF (7)
    Research in vivo (61)
    FCM (82)
    Blocking (2)
    IP (3)
  • Reactivity
    0 selected
    Rabbit (2)
    Rat (21)
    Oryctolagus cuniculus (1)
    Xenopus laevis (1)
    Tupaia belangeri (1)
    Bovine (1)
    Homo sapiens (Human) (5)
    Chlorocebus aethiops (1)
    Pongo abelii (2)
    Bos taurus (4)
    Equus asinus (1)
    Human (129)
    Danio rerio (2)
    Callithrix jacchus (1)
    Macaca fascicularis (2)
    Chicken (1)
    Capra hircus (1)
    Macaca fuscata fuscata (1)
    Ovis aries (2)
    Pagrus major (1)
    Pig (3)
    Macaca mulatta (1)
    Taeniopygia guttata (1)
    Mouse (43)
    Marmota monax (1)
    Tetraodon nigroviridis (1)
    Dog (2)
  • Host species
    0 selected
    Human (75)
    Chimeric (1)
    Rabbit (47)
    Mouse (71)
    Rat (6)
    Humanized (12)
  • Clonality
    0 selected
    Monoclonal (164)
    Polyclonal (47)
  • Conjugate
    0 selected
    PerCP (16)
    PE (16)
    Unconjugated (108)
    FITC (16)
    APC (16)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only